Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1149 | 2819 | 36.4 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
212 | 3 | GASTROENTEROLOGY & HEPATOLOGY//LAPAROSCOPIC CHOLECYSTECTOMY//PRIMARY BILIARY CIRRHOSIS | 51420 |
240 | 2 | LAPAROSCOPIC CHOLECYSTECTOMY//GALLSTONES//CHOLECYSTECTOMY | 20041 |
1149 | 1 | GALLSTONES//CHOLELITHIASIS//CHOLESTEROL GALLSTONES | 2819 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GALLSTONES | authKW | 1349119 | 14% | 32% | 395 |
2 | CHOLELITHIASIS | authKW | 630516 | 8% | 25% | 234 |
3 | CHOLESTEROL GALLSTONES | authKW | 505747 | 3% | 65% | 72 |
4 | GALLSTONE DISEASE | authKW | 383469 | 3% | 42% | 85 |
5 | GALLBLADDER DISEASE | authKW | 187718 | 2% | 33% | 53 |
6 | BILIARY PROTEIN | authKW | 173274 | 1% | 80% | 20 |
7 | CHOLESTEROL CRYSTALLIZATION | authKW | 152556 | 1% | 78% | 18 |
8 | BILIARY LIPIDS | authKW | 147387 | 1% | 41% | 33 |
9 | MINERVA CHOLESTEROL GALLSTONES LIPID METAB | address | 136074 | 1% | 74% | 17 |
10 | NUCLEATION TIME | authKW | 135589 | 1% | 52% | 24 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 54706 | 42% | 0% | 1186 |
2 | Medicine, General & Internal | 1624 | 12% | 0% | 352 |
3 | Surgery | 858 | 11% | 0% | 321 |
4 | Medicine, Research & Experimental | 413 | 6% | 0% | 160 |
5 | Nutrition & Dietetics | 355 | 4% | 0% | 101 |
6 | Biochemistry & Molecular Biology | 261 | 13% | 0% | 357 |
7 | Microscopy | 202 | 1% | 0% | 29 |
8 | Biophysics | 112 | 3% | 0% | 97 |
9 | Medical Laboratory Technology | 78 | 1% | 0% | 32 |
10 | Pathology | 69 | 2% | 0% | 60 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MINERVA CHOLESTEROL GALLSTONES LIPID METAB | 136074 | 1% | 74% | 17 |
2 | INTERNAL PUBL MED | 25358 | 1% | 16% | 15 |
3 | SECT ENDOCRINOL ANDROL METAB DIS | 24366 | 0% | 75% | 3 |
4 | CLIN MED A MURRI | 23147 | 0% | 16% | 13 |
5 | MED GASTROENTEROL CASILLA 114D | 21660 | 0% | 100% | 2 |
6 | GASTROENTEROL BRIGHAM WOMENS HOSP | 14439 | 0% | 67% | 2 |
7 | ALMUSTANSIRIA MED | 10830 | 0% | 100% | 1 |
8 | AMBULATORY PATIENT 421 | 10830 | 0% | 100% | 1 |
9 | AMC LIVER S1 172 | 10830 | 0% | 100% | 1 |
10 | BENGHAZI DIABET ENDOCRINOL | 10830 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEPATOLOGY | 27829 | 6% | 1% | 175 |
2 | JOURNAL OF LIPID RESEARCH | 19424 | 4% | 1% | 124 |
3 | GASTROENTEROLOGY | 19065 | 5% | 1% | 153 |
4 | DIGESTIVE DISEASES AND SCIENCES | 8538 | 4% | 1% | 101 |
5 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 5984 | 3% | 1% | 74 |
6 | GUT | 5707 | 3% | 1% | 71 |
7 | OBESITY SURGERY | 4271 | 1% | 1% | 42 |
8 | ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 3674 | 1% | 2% | 18 |
9 | HIROSHIMA JOURNAL OF MEDICAL SCIENCES | 3344 | 0% | 3% | 10 |
10 | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 3052 | 1% | 1% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GALLSTONES | 1349119 | 14% | 32% | 395 | Search GALLSTONES | Search GALLSTONES |
2 | CHOLELITHIASIS | 630516 | 8% | 25% | 234 | Search CHOLELITHIASIS | Search CHOLELITHIASIS |
3 | CHOLESTEROL GALLSTONES | 505747 | 3% | 65% | 72 | Search CHOLESTEROL+GALLSTONES | Search CHOLESTEROL+GALLSTONES |
4 | GALLSTONE DISEASE | 383469 | 3% | 42% | 85 | Search GALLSTONE+DISEASE | Search GALLSTONE+DISEASE |
5 | GALLBLADDER DISEASE | 187718 | 2% | 33% | 53 | Search GALLBLADDER+DISEASE | Search GALLBLADDER+DISEASE |
6 | BILIARY PROTEIN | 173274 | 1% | 80% | 20 | Search BILIARY+PROTEIN | Search BILIARY+PROTEIN |
7 | CHOLESTEROL CRYSTALLIZATION | 152556 | 1% | 78% | 18 | Search CHOLESTEROL+CRYSTALLIZATION | Search CHOLESTEROL+CRYSTALLIZATION |
8 | BILIARY LIPIDS | 147387 | 1% | 41% | 33 | Search BILIARY+LIPIDS | Search BILIARY+LIPIDS |
9 | NUCLEATION TIME | 135589 | 1% | 52% | 24 | Search NUCLEATION+TIME | Search NUCLEATION+TIME |
10 | GALLSTONE FORMATION | 134949 | 1% | 69% | 18 | Search GALLSTONE+FORMATION | Search GALLSTONE+FORMATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YOO, EH , LEE, SY , (2009) THE PREVALENCE AND RISK FACTORS FOR GALLSTONE DISEASE.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 47. ISSUE 7. P. 795 -807 | 139 | 76% | 16 |
2 | STOKES, CS , KRAWCZYK, M , LAMMERT, F , (2011) GALLSTONES: ENVIRONMENT, LIFESTYLE AND GENES.DIGESTIVE DISEASES. VOL. 29. ISSUE 2. P. 191 -201 | 97 | 75% | 21 |
3 | STINTON, LM , SHAFFER, EA , (2012) EPIDEMIOLOGY OF GALLBLADDER DISEASE: CHOLELITHIASIS AND CANCER.GUT AND LIVER. VOL. 6. ISSUE 2. P. 172 -187 | 98 | 49% | 120 |
4 | SHAFFER, EA , (2006) EPIDEMIOLOGY OF GALLBLADDER STONE DISEASE.BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY. VOL. 20. ISSUE 6. P. 981-996 | 78 | 76% | 188 |
5 | WANG, HH , PORTINCASA, P , WANG, DQH , (2008) MOLECULAR PATHOPHYSIOLOGY AND PHYSICAL CHEMISTRY OF CHOLESTEROL GALLSTONES.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 13. ISSUE . P. 401 -423 | 82 | 79% | 28 |
6 | LAMMERT, F , ACALOVSCHI, M , ERCOLANI, G , VAN ERPECUM, KJ , GURUSAMY, KS , VAN LAARHOVEN, CJ , PORTINCASA, P , (2016) EASL CLINICAL PRACTICE GUIDELINES ON THE PREVENTION, DIAGNOSIS AND TREATMENT OF GALLSTONES.JOURNAL OF HEPATOLOGY. VOL. 65. ISSUE 1. P. 146 -181 | 156 | 26% | 5 |
7 | PAK, M , LINDSETH, G , (2016) RISK FACTORS FOR CHOLELITHIASIS.GASTROENTEROLOGY NURSING. VOL. 39. ISSUE 4. P. 297 -309 | 81 | 68% | 0 |
8 | MARSCHALL, HU , EINARSSON, C , (2007) GALLSTONE DISEASE.JOURNAL OF INTERNAL MEDICINE. VOL. 261. ISSUE 6. P. 529-542 | 92 | 56% | 65 |
9 | JIRSA, M , GROEN, AK , (2001) ROLE OF BILIARY PROTEINS AND NON-PROTEIN FACTORS IN KINETICS OF CHOLESTEROL CRYSTALLISATION AND GALLSTONE GROWTH.FRONTIERS IN BIOSCIENCE. VOL. 6. ISSUE . P. E154 -E167 | 94 | 72% | 8 |
10 | WITTENBURG, H , (2010) HEREDITARY LIVER DISEASE GALLSTONES.BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY. VOL. 24. ISSUE 5. P. 747-756 | 60 | 82% | 17 |
Classes with closest relation at Level 1 |